Cesca Therapeutics (KOOL) Misses Q1 EPS by 2c

Cesca Therapeutics (NASDAQ: KOOL) reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $3.71 million.

For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• S&P 500 may pull back before midterms, but Citi says buy the dip